Company Information

Home | Market | Company Info | Overview

INDUSTRY NEWS

GlaxoSmithKline Pharmaceuticals Ltd.

BSE

Jun 04
3427.35
+203.70 (+ 6.32%)
Volume 12978
Prev. Close 3223.65
Open Price 3300.00
Today's Low / High
3241.05
     
3449.20
Bid Price(Qty.) 0.00 (0)
Offer Pr.(Qty.) 0.00 (0)
52 Wk Low / High
1924.30
     
3449.20

NSE

Jun 04
3420.00
+174.90 (+ 5.39%)
Volume 269490
Prev. Close 3245.10
Open Price 3259.00
Today's Low / High
3238.80
     
3455.90
Bid Price(Qty.) 0.00 (0)
Offer Pr.(Qty.) 0.00 (0)
52 Wk Low / High
1921.00
     
3455.90
You can view the latest news of the Industry.
ISIN No INE159A01016 Market Cap. ( ₹ in Cr. ) 57936.86 P/BV 34.64 Book Value ( ₹ ) 98.74
BSE Code 500660 52 Week High/Low ( ₹ ) 3456/1921 FV/ML 10/1 P/E(X) 62.46
NSE Code GLAXOEQ Book Closure 30/05/2025 EPS ( ₹ ) 54.75 Div Yield (%) 1.58
Date and TimeHeadlines
03/06/2025 15:08 GlaxoSmithKline Phar - Notice Of Shareholders Meetings-XBRL
03/06/2025 15:07 GlaxoSmithKline Phar - Shareholders meeting
03/06/2025 15:05 GlaxoSmithKline Phar - Updates
03/06/2025 14:56 GlaxoSmithKline Phar - 100Th Annual General Meeting On 27Th June 2025
03/06/2025 14:54 GlaxoSmithKline Phar - Business Responsibility and Sustainability Reporting (BRSR)
03/06/2025 14:52 GlaxoSmithKline Phar - Reg. 34 (1) Annual Report.
02/06/2025 19:21 GlaxoSmithKline Phar - Change in Management
02/06/2025 19:20 GlaxoSmithKline Phar - Change in Directors/ Key Managerial Personnel/ Auditor/ Compl...
02/06/2025 19:10 GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Change in Management
16/05/2025 16:18 GlaxoSmithKline Phar - Disclosure Under Regulation 30
16/05/2025 16:14 GlaxoSmithKline Phar - General Updates
16/05/2025 13:48 GlaxoSmithKline Phar - Spurt in Volume
15/05/2025 16:36 GlaxoSmithKline Phar - Analysts/Institutional Investor Meet/Con. Call Updates
15/05/2025 16:34 GlaxoSmithKline Phar - Copy of Newspaper Publication
15/05/2025 16:13 GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Analyst / Investor Me...
14/05/2025 17:02 GlaxoSmithKline Phar - Copy of Newspaper Publication
14/05/2025 17:01 GlaxoSmithKline Phar has declared 420% Final dividend for the financial year March 2...
13/05/2025 19:15 GlaxoSmithKline Phar - Analysts/Institutional Investor Meet/Con. Call Updates
13/05/2025 19:11 GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Analyst / Investor Me...
13/05/2025 17:30 GlaxoSmithKline Phar - Outcome of Board Meeting-XBRL
13/05/2025 17:27 GlaxoSmithKline Phar - Change in Directors/ Key Managerial Personnel/ Auditor/ Compl...
13/05/2025 17:13 GlaxoSmithKline Phar - Appointment Of Parikh & Associates As Secretarial Auditor Of ...
13/05/2025 16:57 GlaxoSmithKline Phar - Outcome of Board Meeting
13/05/2025 16:54 GlaxoSmithKline Phar - Dividend
13/05/2025 16:45 GlaxoSmithKline Phar - Shareholders meeting
13/05/2025 16:44 GlaxoSmithKline Phar - 100Th Annual General Meeting On 27Th June 2025
13/05/2025 16:40 GlaxoSmithKline Phar - Change in Director(s)
13/05/2025 16:39 GlaxoSmithKline Phar - Record Date
13/05/2025 16:38 GlaxoSmithKline Phar - Dividend
13/05/2025 16:36 GlaxoSmithKline Phar - Announcement under Regulation 30 (LODR)-Change in Directorate

TRADEWELL SECURITIES LIMITED
CORPORATE MEMBER OF BOMBAY STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID : 3187  |  NATIONAL STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID: 12835>  |  MULTI COMMODITY EXCHANGE OF INDIA LTD  |  MEMBER ID: 56265
SEGMENTS: BSE CASH  |  BSE STAR MF  |  NSE CASH  |  NSE FO  |  NSE CD  |  NSE MF
SEBI REGN NO. INZ000171936
AMFI ARN CODE: 111875
CDSL DP ID NO. : 12052700 DP SEBI REG.NO.IN-DP-CDSL-432-2007
NSE | BSE | RBI | SEBI | CDSL | MCX | AMFI | SCORES

ATTENTION INVESTORS "Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)


Copyright © 2015 Tradewell Securities Limited. All rights reserved.

Designed, developed and content provided by dion

SMS Registration

Submit Clear

Mobile Trading

Segment

Submit Clear

logo

Submit Clear

Investors Grievances

igtsl@tradewellmail.com

Invest By QFI

QFI's Can now invest in Indian Capital Markets Through Tradewell Securities ltd -
For details Contact
Mr K.Brahmaiah - 9246399440/040-23541258.

CLIENT LOGIN

NOTES:

FRANCHISEE LOGIN

NOTES:

INTERNET TRADING

NOTES: